Jan 29 (Reuters) -
APIMEDS PHARMACEUTICALS US INC - IPO PRICE RANGE EXPECTED BETWEEN $4.00 AND $5.00
APIMEDS PHARMACEUTICALS US INC SEES IPO OF UP TO 4.5 MILLION SHARES OF COMMON STOCK
Source text: [ID:n0001213900-25-007894]
Further company coverage: [ ]